Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 3 1

Status

Unknown 2Completed 1

Sponsor Class

OTHER 7NIH 3OTHER_GOV 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Rectal Neoplasms 3Colorectal Neoplasms 3Colonic Neoplasms 3

Interventions

Cyclophosphamide 385Specimen Handling 371Magnetic Resonance Spectroscopy 325Radiotherapy 306Biopsy 269Cisplatin 257Carboplatin 253Paclitaxel 235Doxorubicin 226Fluorouracil 200Etoposide 197Vincristine 182Bevacizumab 180Filgrastim 170Gemcitabine 163Leucovorin 149Cytarabine 144aldesleukin 140Taxes 127Docetaxel 122Oxaliplatin 113Chemotherapy, Adjuvant 113fludarabine phosphate 111Rituximab 107Methotrexate 107Radiation 106Bortezomib 105Prednisone 102Irinotecan 100Dexamethasone 100

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
NIH × Interventional × Occult Blood × Clear all
NCT00355004 2013-12-19

Computerized and Mailed Reminders in Increasing the Rate of Colorectal Cancer Screening in Adults With an Average Risk for Colorectal Cancer

National Cancer Institute (NCI)

Phase NA Completed
21,860 enrolled
Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT00617071 2013-12-18

Personalized Screening Plans to Increase Colorectal Cancer Screening in Healthy Participants

National Cancer Institute (NCI)

Phase 3 Unknown
900 enrolled
Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT01032746 2013-12-18

Personal Electronic Health Records in Improving Screening Rates for Colorectal Cancer

National Cancer Institute (NCI)

Phase NA Unknown
1,000 enrolled
Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡